BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2381987)

  • 1. Self-reports in chronic schizophrenic patients with primary negative symptoms: preliminary results.
    Gerbaldo H; de las Carreras C; Osuna A; Laves GS; Orlando JC
    Pharmacopsychiatry; 1990 Jul; 23(4):195-7. PubMed ID: 2381987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary experiences and results with the Munich version of the Andreasen Scale. Assessment of productive and negative symptoms in chronic schizophrenic patients.
    Dieterle DM; Albus MI; Eben E; Ackenheil M; Rockstroh W
    Pharmacopsychiatry; 1986 May; 19(3):96-100. PubMed ID: 2873602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of primary negative symptoms in schizophrenic and other psychiatric patients].
    Gerbaldo H; Müller-Siecheneder F
    Fortschr Neurol Psychiatr; 1996 Jun; 64(6):221-7. PubMed ID: 8766995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depressive symptoms and negative symptoms during schizophrenia].
    Dollfus S; Langlois S; Assouly-Besse F; Petit M
    Encephale; 1995 Jun; 21 Spec No 3():23-7. PubMed ID: 7628337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
    Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
    Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC; Yon V; Loas G; Noisette C
    Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom stability in geriatric chronic schizophrenic inpatients: a one-year follow-up study.
    Putnam KM; Harvey PD; Parrella M; White L; Kincaid M; Powchik P; Davidson M
    Biol Psychiatry; 1996 Jan; 39(2):92-9. PubMed ID: 8717606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Self-rating scales in schizophrenia: assessment of the practical applicability of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogue scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):315-35. PubMed ID: 12776661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inter-observer reliability of negative schizophrenic symptoms].
    Peralta Martín V; Cuesta Zorita MJ; de León J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(4):221-5. PubMed ID: 1957714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.
    Selten JP; Wiersma D; van den Bosch RJ
    Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Follow-up dynamics of schizophrenic diseases in adolescence].
    Schulz E; Martin M; Remschmidt H
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):262-74. PubMed ID: 7856322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.